USD 12.31
(-2.38%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 24.1 Million USD | 122.22% |
2022 | -174.13 Million USD | -3394.59% |
2021 | -393.2 Million USD | -90.23% |
2020 | 34.36 Million USD | -31.93% |
2019 | 79.42 Million USD | 129.91% |
2018 | 34.92 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 22.21 Million USD | -56.11% |
2024 Q2 | -14.31 Million USD | -162.83% |
2023 Q2 | -23.98 Million USD | -234.59% |
2023 FY | - USD | 122.22% |
2023 Q4 | 51.9 Million USD | 515.86% |
2023 Q3 | -12.48 Million USD | 47.95% |
2023 Q1 | 17.81 Million USD | 116.3% |
2022 Q1 | 577 Thousand USD | 104.61% |
2022 Q3 | -20.81 Million USD | 58.06% |
2022 Q2 | -49.62 Million USD | -8700.0% |
2022 FY | - USD | -3394.59% |
2022 Q4 | -109.3 Million USD | -425.19% |
2021 Q4 | -12.51 Million USD | 44.42% |
2021 Q2 | 6.74 Million USD | -74.8% |
2021 FY | - USD | -90.23% |
2021 Q1 | 26.75 Million USD | -83.96% |
2021 Q3 | -22.51 Million USD | -433.96% |
2020 Q2 | 25.91 Million USD | -24.59% |
2020 FY | - USD | -31.93% |
2020 Q1 | 34.36 Million USD | -73.53% |
2020 Q4 | 166.8 Million USD | 195.71% |
2020 Q3 | -174.28 Million USD | -772.52% |
2019 Q4 | 129.79 Million USD | 0.0% |
2019 FY | - USD | 129.91% |
2019 Q1 | 6.57 Million USD | 0.0% |
2019 Q2 | 17.17 Million USD | 161.34% |
2018 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CorVel Corporation | 121.35 Million USD | 80.137% |
eHealth, Inc. | -9.15 Million USD | 363.202% |
Erie Indemnity Company | 568.01 Million USD | 95.756% |
Reliance Global Group, Inc. | -8.92 Million USD | 370.156% |
Reliance Global Group, Inc. | -8.92 Million USD | 370.156% |
Tian Ruixiang Holdings Ltd | -2.93 Million USD | 920.822% |
Willis Towers Watson Public Limited Company | 2.33 Billion USD | 98.968% |